Table 1.
Peptide | Name | Sequence and Modification |
---|---|---|
H3(1–17) | Control | ARTKQTARKSTGGKAPR |
H3(1–17) | H3K4me3 | ARTK(me3)QTARKSTGGKAPR |
H3(1–17) | H3K9ac | ARTKQTARK(ac)STGGKAPR |
H3(1–17) | H3K9cr | ARTKQTARK(cr)STGGKAPR |
H3(1–17) | H3K9bu | ARTKQTARK(bu)STGGKAPR |
H3(1–17) | H3K9hib | ARTKQTARK(hib)STGGKAPR |
H3(1–17) | H3R2meK4me3 | AR(me)TK(me3)QTARKSTGGKAPR |
H3(1–17) | H3T3phK4me3 | ART(ph)K(me3)QTARKSTGGKAPR |
H3(1–17) | H3K4me3K9ac | ARTK(me3)QTARK(ac)STGGKAPR |
H3(1–17) | H3K4me3K9bu | ARTK(me3)QTARK(bu)STGGKAPR |
H3(1–17) | H3K4me3K9cr | ARTK(me3)QTARK(cr)STGGKAPR |
H3(1–17) | H3K4me3K9hib | ARTK(me3)QTARK(hib)STGGKAPR |
aAbbreviation of acylation modifications: methylation (me), tri-methylation (me3), acetylation (ac), phosphorylation (ph), butyrylation (bu), crotonylation (cr), succinylation (su), and 2-hydroxybutyrylation (hib).